Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of manufacturing ...

New “Danaher Beacon,” first in the European Union, aims to accelerate translation, scalability, and reliability across cell and gene therapy ...

AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ -- Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges ...

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities. Cytiva has acquired CEVEC Pharmaceuticals, a Germany-based provider of ...

Cytiva needed to expand its clean room capabilities to install additional and updated liquid pharmaceutical formulation and bottling equipment, which involved a new stand-alone structure on the Cytiva ...

Cytiva and the life sciences business of Pall are now one business under the Cytiva brand. With nearly 16,000 associates in 40 countries, and more than 300 years’ heritage of expertise, the new Cytiva ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated ...

Cytiva announced in a Feb. 1, 2021 press release that it had acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines. It is Cytiva’s first acquisition since ...

Cytiva as well as Newark-based BioCentriq were awarded funding to accelerate bringing gene therapies to market as part of a grant round from the National Institute for Innovation in Manufacturing ...

Cytiva, the former GE Healthcare Life Sciences, as well as Pall Corp., which specializes in high-tech filtration, separation and purification, announced on Tuesday a plan to invest $1.5 billion ...

Nuclera, has announced a collaboration with Cytiva. This collaboration is focused on accelerating the production, purification and characterization of proteins ...